Latest news and articles about clinical trials from NEX English
A new study reveals that a gene-editing drug has successfully lowered harmful cholesterol levels by <strong>62%</strong> in a small group of <strong>35 participants</strong>. These promising results could lead to new treatments for heart disease.
Biogen has announced its progress in developing an experimental drug for Alzheimer’s disease, moving to the final stage of clinical trials despite previous disappointing results. The data suggests that the treatment reduces tau protein levels and slows cognitive decline.
Erasca, a company specializing in cancer drug development, saw its shares drop by 55% on Tuesday following the withdrawal and subsequent death of a patient in its clinical trial due to severe side effects. This incident has raised widespread concerns about the safety of new drugs.
Saudi Arabia announced a rise in average life expectancy from 74 years in 2016 to 79.9 years by the end of 2025, attributed to the health sector transformation program. This improvement is linked to a significant increase in clinical trials, which saw a 51.4% rise between 2023 and 2025.
The Saudi Health Sector Transformation Program has announced significant achievements in the healthcare system, raising the average life expectancy from <strong>74 years</strong> in 2016 to <strong>79.9 years</strong> by the end of 2025, bringing the Kingdom closer to its Vision 2030 goals.
Blockstone has announced the closure of its latest life sciences fund, raising a total of <strong>$6.3 billion</strong>. This significant amount marks the largest fundraising effort by the company to support clinical trials for drugs and technologies in a time of increasing investments in the healthcare sector.
The CEO of Apyvax stated that the company is not in a hurry to sell itself, planning to raise funds after releasing critical trial data in June. This comes amid strong rumors of a potential acquisition by major pharmaceutical companies.
Pfizer, in collaboration with French partner Valneva, announced its intention to seek regulatory approval for a Lyme disease vaccine after successful advanced clinical trials. This initiative comes amid growing interest in new methods to combat this globally significant health threat.